JFG
ANIP icon

Jefferies Financial Group’s ANI Pharmaceuticals ANIP Stock Holding History

Jefferies Financial Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
3,261
-8,739
-73% -$701K ﹤0.01% 1410
2026
Q1 		$923K Hold
12,000
– – 0.01% 961
2025
Q4 		$947K Buy
+12,000
New +$1.04M ﹤0.01% 1112

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group's ANIP Position: Q2 2026 in Review

Jefferies Financial Group reduced its ANI Pharmaceuticals (ANIP) stake by 73% in Q2 2026, selling an estimated $701K and leaving 3,261 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Jefferies Financial Group first reported a position in ANIP in Q4 2025 and has held it in 3 quarters since. The position peaked at $947K in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Jefferies Financial Group held 3,261 shares of ANI Pharmaceuticals worth $270K as of Q2 2026.
  • Jefferies Financial Group sold 8,739 ANI Pharmaceuticals shares in Q2 2026, an estimated $701K.
  • ANI Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1410 holding.
  • Jefferies Financial Group first reported a position in ANI Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Jefferies Financial Group's ANI Pharmaceuticals position peaked at $947K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.